Teva buys generic medicine division of its chief competitor Prior to the $40 billion purchase, Teva was already the world’s largest manufacturer of generic drugs.
Report: Israeli exec says Avis refused to rent a car over his nationality The Teva vice president said the manager at a Manhattan location backed a reservations agent’s claim that it was company policy not to recognize Israeli documents.
Swiss pharmaceutical company ups investment in Israeli biotech firm Novartis puts extra $15m into Gamida Cell, which performs stem cell research on how to beat cancer.
